Filter Results:
(110)
Show Results For
- All HBS Web
(110)
- News (42)
- Research (59)
- Multimedia (1)
- Faculty Publications (35)
Show Results For
- All HBS Web
(110)
- News (42)
- Research (59)
- Multimedia (1)
- Faculty Publications (35)
Page 1 of 110
Results →
- March 2023 (Revised March 2025)
- Case
Close Concerns: Diabetes Research and Advocacy
By: Regina Herzlinger and Brian L. Walker
Diagnosed with diabetes at the age of 18, Kelly Close understood the importance of balancing consistency and iteration. This principle had also informed her professional work, which started with a rapid promotion from financial analyst at Goldman Sachs to an analyst... View Details
- October 2009 (Revised January 2010)
- Case
The Joslin Diabetes Center
By: Michael E. Porter, Elizabeth Olmsted Teisberg and Scott Wallace
The Joslin Diabetes Center in Boston, Massachusetts is a leading center for diabetes care, clinician training, and research. The incidence of diabetes is rising precipitously worldwide, challenging quality of life with its complications and rapidly accelerating health... View Details
Keywords: Integration; Service Delivery; Medical Specialties; Health Care and Treatment; Outcome or Result; Corporate Finance; Health Industry; Boston
Porter, Michael E., Elizabeth Olmsted Teisberg, and Scott Wallace. "The Joslin Diabetes Center." Harvard Business School Case 710-424, October 2009. (Revised January 2010.)
- March 2017
- Case
From mHealth Hackathon to Reality: Diabetes Care
By: Kevin Schulman and Curry Cheek
This case explores the development of a business plan for a mobile health application for diabetes care. The case depicts a student team excited about the opportunity to improve the care of patients with diabetes by contracting an app. They go through a rigorous... View Details
Keywords: Innovation; Mobile Health Technologies; Health Care; Health Care Industry; Behavioral Economics; Applications and Software; Health Care and Treatment; Mobile and Wireless Technology; Innovation and Invention; Health Industry; Telecommunications Industry
Schulman, Kevin, and Curry Cheek. "From mHealth Hackathon to Reality: Diabetes Care." Harvard Business School Case 317-105, March 2017.
- 17 Nov 2003
- Research & Ideas
The Business Case for Diabetes Disease Management
end, participants agreed that while disease management is a thorny concept involving all these many constituencies, it might in some instances leave room for business potential in the form of a carve-out. A carve-out, as defined in the paper "The Business Case for... View Details
- January 2010
- Teaching Note
The Joslin Diabetes Center (TN)
By: Michael E. Porter, Elizabeth O. Teisberg and Scott Wallace
Teaching Note for [710424]. View Details
- November 1998
- Case
Wegmans Food Markets: Diabetes Counseling
By: Ray A. Goldberg, David E. Bell and Ann Leamon
Danny Wegman, president of Wegmans Food Markets, is trying to decide how to evaluate the success of a nutrition-counseling program for diabetics, and whether and how to expand the program beyond the two stores currently involved. Wegmans, with 57 stores and $2.3... View Details
Keywords: Performance Evaluation; Expansion; Programs; Human Needs; Financial Management; Health Care and Treatment; Nutrition; Consumer Behavior; Pharmaceutical Industry; Food and Beverage Industry
Goldberg, Ray A., David E. Bell, and Ann Leamon. "Wegmans Food Markets: Diabetes Counseling." Harvard Business School Case 599-057, November 1998.
- November 2001 (Revised September 2004)
- Case
Evolution of Treatment, The: The Case of Diabetes
By: Richard M.J. Bohmer, Jeffrey D. Street and Laura Feldman
Scientific knowledge surrounding diabetes mellitus has grown over the last century to include its cause, treatment, and prevention strategies. However, the type and level of care that patients receive is suboptional. This case examines the forces in industry,... View Details
Keywords: Policy; Health Care and Treatment; Innovation and Management; Knowledge Use and Leverage; Management; Management Analysis, Tools, and Techniques; Health Industry
Bohmer, Richard M.J., Jeffrey D. Street, and Laura Feldman. "Evolution of Treatment, The: The Case of Diabetes." Harvard Business School Case 302-023, November 2001. (Revised September 2004.)
- April 2009
- Teaching Note
Amylin Pharmaceuticals: Diabetes and Beyond (TN)
By: Richard G. Hamermesh and Rachel Gordon
Teaching Note for [809011]. View Details
- February 1996 (Revised April 2004)
- Case
Eli Lilly and Company: Innovation in Diabetes Care
By: Clayton M. Christensen
Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details
Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry
Christensen, Clayton M. "Eli Lilly and Company: Innovation in Diabetes Care." Harvard Business School Case 696-077, February 1996. (Revised April 2004.)
- 03 Feb 2010
- News
Competition Seeks Ideas About Diabetes
- February 1999
- Teaching Note
Wegmans Food Markets: Diabetes Counseling TN
By: David E. Bell
Teaching Note for (9-599-057). View Details
- 24 Apr 2014
- News
Fighting the diabetes epidemic using mobile phones
Through Jana Care, a start-up he cofounded in Bangalore, India, Sidhant Jena (SPH 2011, MBA 2011) is building affordable diagnostics and evidence-based lifestyle coaching programs on mobile phones to make diabetes management cheaper,... View Details
- December 2008 (Revised October 2013)
- Case
Amylin Pharmaceuticals: Diabetes and Beyond (A)
By: Richard G. Hamermesh and Rachel Gordon
Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a... View Details
Keywords: Regulations; Drug Regulations; Symlin; Negotiation; Governing Rules, Regulations, and Reforms; Resource Allocation; Negotiation Deal; Product Development; Research and Development; Commercialization; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Rachel Gordon. "Amylin Pharmaceuticals: Diabetes and Beyond (A)." Harvard Business School Case 809-011, December 2008. (Revised October 2013.)
- January 2023
- Case
Vertex and the Cure for Type 1 Diabetes
By: Amitabh Chandra, William J Anderson and Silvia Mare
Keywords: Biotechnology Industry
- March 1997
- Teaching Note
Eli Lilly and Company: Innovation in Diabetes Care TN
By: Clayton M. Christensen and Bret J. Baird
Teaching Note for (9-696-077). View Details
Keywords: Pharmaceutical Industry
- September 2004 (Revised November 2006)
- Teaching Note
Evolution of Treatment, The: The Case of Diabetes
By: Richard M.J. Bohmer
Teaching Note to (9-302-023). View Details
- February 2019
- Article
Who Benefits Most in Disease Management Programs: Improving Target Efficiency
By: Timothy Simcoe, Maryaline Catillon and Paul Gertler
Disease management programs aim to reduce cost by improving the quality of care for chronic diseases. Evidence of their effectiveness is mixed. Reducing health care spending sufficiently to cover program costs has proved particularly challenging. This study uses a... View Details
Keywords: Health Economics; Target Efficiency; Diabetes; Disease Management; Program Evaluation; Heterogeneity; Economics; Health; Quality; Health Care and Treatment; Cost Management; Health Industry
Simcoe, Timothy, Maryaline Catillon, and Paul Gertler. "Who Benefits Most in Disease Management Programs: Improving Target Efficiency." Health Economics 28, no. 2 (February 2019): 189–203.